| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 5. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | azelastine hydrochloride/fluticasone propionate (Dymista®) |
| Formulation | 137 micrograms/50 micrograms nasal spray |
| Reference number | 1274 |
| Indication | Relief of symptoms of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocortocoid is not considered sufficient |
| Company | Meda Pharmaceuticals Ltd |
| BNF chapter | Ear, nose & oropharynx |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 17/04/2013 |